ArticleJournal of clinical and translational hepatology2025

Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.

Honglian Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.